Accentia files reorganization plan

Tampa, FL-based Accentia Biopharmaceuticals, which filed for bankruptcy in 2008, has filed a proposed reorganization plan to help it emerge from Chapter 11 protection this summer as a fully restructured company. The plan is expected to support the regulatory advancement of the autoimmune disease therapy, Revimmune, a drug regimen designed to "reboot" the immune system to potentially eliminate multiple sclerosis and significantly reduce disability, the company says in a statement. "Our...